Exherin is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities and selectively and competitively binds to and blocks N-cadherin.

Exherin is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities and selectively and competitively binds to and blocks N-cadherin.

Exherin is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities and selectively and competitively binds to and blocks N-cadherin.

Exherin is a small, cyclic pentapeptide vascular-targeting agent with potential antineoplastic and antiangiogenic activities and selectively and competitively binds to and blocks N-cadherin.

EXP 3174 is a selective and noncompetitive antagonist of AT1 receptor with IC50 of 37 nM.

EXP 3174 is a selective and noncompetitive antagonist of AT1 receptor with IC50 of 37 nM.

EXP 3174 is a selective and noncompetitive antagonist of AT1 receptor with IC50 of 37 nM.

EXP 3174 is a selective and noncompetitive antagonist of AT1 receptor with IC50 of 37 nM.

F16 is a small molecule that selectively inhibits proliferation of mammary epithelial, neu-overexpressing cells, as well as a variety of mouse mammary tumor and human breast cancer cell lines.

F16 is a small molecule that selectively inhibits proliferation of mammary epithelial, neu-overexpressing cells, as well as a variety of mouse mammary tumor and human breast cancer cell lines.

F16 is a small molecule that selectively inhibits proliferation of mammary epithelial, neu-overexpressing cells, as well as a variety of mouse mammary tumor and human breast cancer cell lines.

Fadrozole is a selective aromatase inhibitor that has been introduced in Japan for the treatment of breast cancer.

Fadrozole is a selective aromatase inhibitor that has been introduced in Japan for the treatment of breast cancer.

Fadrozole is a selective aromatase inhibitor that has been introduced in Japan for the treatment of breast cancer.

Fadrozole is a selective aromatase inhibitor that has been introduced in Japan for the treatment of breast cancer.

Fadrozole is a selective aromatase inhibitor that has been introduced in Japan for the treatment of breast cancer.

Fadrozole is a selective aromatase inhibitor that has been introduced in Japan for the treatment of breast cancer.

Fadrozole HCl specifically inhibits aromatase, blocking the aromatization of androstenedione and testosterone into estrone and estradiol, respectively.

Fadrozole HCl specifically inhibits aromatase, blocking the aromatization of androstenedione and testosterone into estrone and estradiol, respectively.

Fadrozole HCl specifically inhibits aromatase, blocking the aromatization of androstenedione and testosterone into estrone and estradiol, respectively.

Fadrozole HCl specifically inhibits aromatase, blocking the aromatization of androstenedione and testosterone into estrone and estradiol, respectively.

Fadrozole HCl specifically inhibits aromatase, blocking the aromatization of androstenedione and testosterone into estrone and estradiol, respectively.

Fadrozole HCl specifically inhibits aromatase, blocking the aromatization of androstenedione and testosterone into estrone and estradiol, respectively.

D-Fagomine is an iminosugar originally isolated from seeds of buckwheat (Fagopyrum sculentum Moench), present in the human diet and now available as a pure crystalline product.

D-Fagomine is an iminosugar originally isolated from seeds of buckwheat (Fagopyrum sculentum Moench), present in the human diet and now available as a pure crystalline product.

D-Fagomine is an iminosugar originally isolated from seeds of buckwheat (Fagopyrum sculentum Moench), present in the human diet and now available as a pure crystalline product.

Falecalcitriol is an analog of calcitriol with a higher potency both in vivo and in vitro systems, and longer duration of action in vivo.

Falecalcitriol is an analog of calcitriol with a higher potency both in vivo and in vitro systems, and longer duration of action in vivo.